AGENDA – NOVEMBER 7 – 9, 2019
7:00-7:10am
Welcome and Introduction
Ash Tewari, MBBS, MCh7:10-7:45am
The Hans E. Shapira Lecture
Prostate Cancer: A Perspective; the Right Treatment for the Right Patient
at the Right Time
Joseph A. Smith, MD EPIDEMIOLOGY, SCREENING AND DIAGNOSIS OF PROSTATE CANCER
7:45-8:00am
Epidemiology of Prostate Cancer
Prof. Olof Akre, MD, PhD8:00-8:15am
Current Status of Prostate Cancer Screening: There is a Smarter Way
Quoc-Dien Trinh, MD8:15-9:40am
3D Live Surgery: Robot-Assisted Radical Prostatectomy
Surgeon:
Moderators:
9:40-9:50am
Q&A for Live Surgery
9:50-10:05am
BREAK / VISIT EXHIBITS
RACIAL DISPARITIES SESSION
10:05-10:35am
Genomics, Radiomics and Racial Disparities in Prostate Cancer
Ash Tewari, MBBS, MCh10:35-10:50am
Racial Disparities in Prostate Cancer: Patient Network Activation
Nihal Mohamed, PhD10:50-11:05am
Biomarkers in Prostate Cancer: How Far Can the AR Lead Us?
Jun Luo, PhD11:05-11:20am
Molecular Exploitation of Prostate Tumors for Targeted Therapies
John Isaacs, PhD11:20-11:35am
Artificial Intelligence in Prostate Cancer Detection/Strategic Considerations
Rakesh Shiradkar, PhD11:35-11:45am
Q & A
11:45-1:00pm
LUNCH
MAIN AFTERNOON SESSION
IMAGING AND BIOPSY IN PROSTATE CANCER
Chairs:
1:00-1:15pm
KEYNOTE: Clinical Trials of Neoadjuvant ADT and Immunotherapy for
Localized Prostate Cancer
J. Kellogg Parsons, MD 1:15-1:30pm
Learning After 12,000 Cases
Vipul Patel, MD, FACS1:30-1:40pm
Confocal Fluorescence Digital Intraoperative Histopathological Imaging —
The Better Frozen Section?
Jorn H. Witt, MD 1:40-1:55pm
Advances in Prostate MR Imaging
Bachir Taouli , MD, MHA1:55-2:10pm
7TMRI Imaging in Prostate Cancer
Matthieu Durand, MD, PhD2:10-2:25pm
When to Skip Biopsy: Before Diagnosis, During AS, Follow-Up of FT
Prof. Arnauld Villers, MD, PhDQ&A / Audience Response Question with App
IMMUNOTHERAPY AND PROSTATE CANCER
2:25-2:55pm
KEYNOTE:
Monitoring Immunotherapy in Prostate Cancer
Susan F. Slovin, MD, PhD 2:55-3:10pm
Immunotherapy Strategies in Biochemically Recurrent Prostate Cancer
Ravi Madan, MD3:10-3:25pm
Immunotherapy for Prostate Cancer in a Neoadjuvant Setting
Sujit S. Nair, PhD3:25-3:40pm
Audience Response Question with App/Coffee Break
FOCAL THERAPY
3:40-3:50pm
Focal Therapy: Is It Ready for Prime Time?
Herbert Lepor, MD3:50-4:00pm
Focal Therapy: New Nano Frontier
Art Rastinehad, DO4:00-4:10pm
Partial Gland Ablation and Focal Therapy for Prostate Cancer
Jonathan A. Coleman, MD4:10-4:20pm
The Role of Salvage Cryotherapy and the Outcomes
Aaron E. Katz, MD4:20-4:30pm
The Role of Local Therapy in Oligometastatic PCa
Prasanna Sooriakumaran, MD, PhD, FRCS Urol, FEBUMANAGEMENT OF LOW AND INTERMEDIATE RISK PROSTATE CANCER
4:30-4:40pm
Pelvic Musculature and Innervation After Surgery
Thomas Bessede, MD, PhD4:40-4:50pm
Global Perspectives in Robotic Surgery: A Healthy Market is a Competitive One
Prof. Maurizio Buscarini, MD, PhD, MPH-MBA4:50-5:00pm
Complications of Robot-Assisted Laparoscopic Surgery Distant from the Surgical Site
Daniel Gainsburg, MD, MS5:00-5:10pm
Treatment of Locally Recurrent Prostate Cancer After Whole Gland Cryotherapy
Using CyberKnife
Jonathan Haas, MD 5:10-5:20pm
RARP: Surgical Steps for Better Oncological and Functional Outcomes
Jorn H. Witt, MDRADICAL PROSTATECTOMY (Part 1)
5:20-5:30pm
Management of Lymph Node-Positive Prostate Cancer and Neoadjuvant Systemic
Therapy in Localized Prostate Cancer
Brian F. Chapin, MD 5:30-5:40pm
Radical Prostatectomy in Oligometastatic Disease: Experience from the UK RCT
TRoMbone
Prasanna Sooriakumaran, MD, PhD, FRCS Urol, FEBU 5:40-5:50pm
Cytoreductive Radical Prostatectomy in Men with M1a or M1b Disease
Prof. Isaac Yi Kim, MD, PhD, MBA5:50-6:00pm
Role of Surgery in Advanced Disease and Salvage Lymph Node Dissections
Vincent Laudone, MD6:00-6:10pm
Outcomes from the Swedish LAPPRO Trials: Lessons Learned
Peter Wiklund, MD, PhD6:10-6:15pm
Conclusion
Ash Tewari, MBBS, MChBREAKOUT SESSION:
TARGETING THE PROSTATE MICROENVIRONMENT: CELLULAR, CLINICAL, SURGICAL
1:00-1:15pm
Translating the Biology of Prostate-Specific Membrane Antigen into an Optimal Therapeutic Target
Scott T. Tagawa, MD, MS, FACP1:15-1:30pm
New Therapies for Castrate-Resistant Bone-Metastatic Prostate Cancer
Alexander Kirschenbaum, MD1:30-1:45pm
Targeting DNA Repair Deficiency in Prostate Cancer
Joseph W. Kim, MD1:45-2:00pm
Hormonal Control of Prostate Tumor Microenvironment
Alice C. Levine, MD2:00-2:20pm
Phenotypic Reprogramming in Treatment Resistance
Natasha Kyprianou, MBBS,PhD2:20-2:45pm
Break
2:45-3:00pm
Same Old Sling? The Evolution of Perineal Sling Surgery for Treatment of
Post-Prostatectomy Incontinence
Neil H. Grafstein, MD 3:00-3:15pm
Quality of Life After Urologic Cancer
Gerardo J. Fernandez, MD3:15-3:30pm
Luminal Water Imaging for Noninvasive Characterization of Prostate Cancer Aggressiveness
Stefanie Hectors, PhD3:30-3:45pm
Overcoming Challenges in the Endoscopic Management of Radiation Strictures
Jerry Blaivas, MD3:45-4:00pm
Q & A
4:00-4:15pm
STATE OF THE ART LECTURE:
Metabolic Vulnerability of Prostate Cancer PTEN Inactivation
Ramon Parsons, MD, PhD 4:15-6:15pm
JOIN THE MAIN SESSION
7:00-7:10am
Day Two Welcome
Ash Tewari, MBBS, MChRADICAL PROSTATECTOMY (Part 2)
7:10-8:10am
Mind/Body Cancer Connection
Deepak Chopra, MD, FACP8.10-8:40am
Robot-Assisted Radical Prostatectomy
Ash Tewari, MBBS, MCh8:40-9:40am
3D Surgery: Robot-Assisted Radical Prostatectomy
2 cases, Pre-taped
Chair:
Surgeon:
9:40-9:45am
Q&A (Live Surgery)
9:45-10:00am
Audience Response Question with App
BREAK / VISIT EXHIBITS
SURS – Panel Discussion
NAILING PROSTATE CANCER: WHICH TECHNIQUES, WHY, WHEN AND HOW?
10:00-10:15am
Value of 4K Score in Patients on Active Surveillance
Mitchell C. Benson, MD10:15-10:30am
Outpatient Single Port Extra Peritoneal RRP
Jihad Kaouk, MD10:30-10:45am
Outpatient Prostatectomy
David Lee, MD, FACS10:45-11:00am
“Peritoneal Scaffold” in Radical Prostatectomy
Mallikarjuna Chiruvella, MBBS, MS, MCh11:00-11:15am
Retzius-Sparing Trans-Douglas Radical Prostatectomy
Markus Hohenfellner, MD11:15-11:30am
3D Image-Guided Surgery in Prostate Cancer: From Cognitive to Augmented Reality Procedures
Prof. Francesco Porpiglia, MD11:30-11:45am
Less is More for Prostate Cancer
Prof. Abhay Rane, OBE11:45-12:00pm
Radiotherapy and Impaired Intestinal Health – Lifelong Low-Grade Inflammation and the Role of Diet in Prevention
Prof. Gunnar N. Steineck, MD, PhD12:00-12:15pm
Postoperative Opioid Use After Radical Prostatectomy
Misop Han, MD12:15-12:30pm
Which Pre-treatment Risk Stratification Tool Predicts Best? Testing Predictive Performance in a Nationwide Population
Prof. Olof Akre, MD, PhD12:30-12:40pm
Brachytherapy in Prostate Cancer Treatment
Richard G. Stock, MD12:40-1:40pm
LUNCH
MAIN AFTERNOON SESSION:
ADVANCED PROSTATE CANCER
Chair:
Audience Response Question with App
1:40-1:55pm
Targeting Metabolic Alterations
Christopher J. Logothetis, MD1:55-2:10pm
Surgical Management of Advanced Prostate Cancer
Ganesh Palapattu, MD, FACS2:10-2:25pm
Medical Management of Metastatic Prostate Cancer
Simon Hughes, MBBS, FRCP, FRCR, MD (res), FHEA2:25-2:40pm
Novel Therapeutics for Advanced Prostate Cancer
Ganesh Raj, MD, PhD2:40-2:55pm
Recent Advances in Management of Advanced Prostate Cancer
William K. Oh, MD2:55-3:10pm
Promising Clinical Trials in Prostate Cancer
Cora N. Sternberg, MD, FACP3:10-3:25pm
PRINT Study: Therapeutic Impact So Far
Bobby Liaw, MD3:25-3:40pm
BREAK / VISIT EXHIBITS
SEXUAL HEALTH FOLLOWING PROSTATECTOMY
3:40-3:50pm
Sexual Function After RALP
Doron S. Stember, MD3:50-4:00pm
Emerging Treatment Options for Post-Prostatectomy Climacturia
Robert J. Valenzuela, MD, FACS4:00-4:10pm
Treatment of Male Hypogonadism Using Non-Testosterone Therapies
Doron S. Stember, MD4:10-4:20pm
Management of BPH in Active Surveillance Patients
Steven Kaplan, MD, FACSAFTERNOON SESSION II:
INNOVATIONS IN URO-PATHOLOGY/ONCOLOGY
4:20-4:35pm
Keynote: Prostate Tumor Grading in 21st Century Patients
Jonathan I. Epstein, MD4:35-4:50pm
Novel Metabolic Profiling in Advanced Prostate Cancer
Massimo Loda, MD4:50-5:05pm
Targeting the Reactive Stroma
Gustavo E. Ayala, MD5:05-5:20pm
Gene-Oncogene Interactions
Carlos Cordon-Cardo, MD, PhD5:20-5:35pm
Castrate Resistant Prostate Cancer:
Therapeutic Targets from Metabolic and Genomic Profiles
Dimple Chakravarty, PhD 5:35-5:45pm
Awards Presentation and Closing Remarks
Ash Tewari, MBBS, MCh6:30pm
Faculty Dinner (Details to come)
The PierreBREAKOUT SESSION:
Management of Prostate Cancer Patients/Quality of Life
2:00-2:15pm
Possible Application of Systematic Light Exposure to Treat Obese Frailty in Men with Advanced Stage Prostate Cancer
William H. Redd, PhD2:15-2:30pm
Management of Incontinence After Radiation or Surgery
Rajveer S. Purohit, MD, MPH2:30-2:45pm
Pre-Rehabilitation Interventions in Prostate Cancer Surgery
Bente Thoft Jensen, PhD, MPH2:45-3:00pm
Impact of Smoking on Treatment Outcomes
Nihal Mohamed, PhD3:00-3:15pm
Management of Prostate Cancer
Alexander Kirschenbaum, MD3:15-3:30pm
Social Media Transforming Medicine
Nate Gross, MD3:30-3:45pm
Urinary Adverse Events After Prostate Cancer Treatment (RP, RT, etc.)
Jaspreet S. Sandhu, MD3:45-4:00pm
Teamwork and Safety Conversations to Prevent Wrong Site Surgery
Amanda Rhee, MD, MS4:00-5:45pm
JOIN THE MAIN SESSION
KIDNEY AND BLADDER CANCER
In Collaboration with Society of Urologic Robotic Surgeons
and Endourological Society
7:00-7:10am
DAY THREE WELCOME Stern Auditorium
Ketan K. Badani, MDSESSION I: UPPER TRACT DISEASE
Chairs:
7:10-7:25am
Endoscopic Management of Bulky Upper Tract Urothelial Carcinoma
Majid Eshghi, MD, FACS, MBA7:25-7:35am
Endoscopic Management
Mantu Gupta, MD, FRCS7:35-7:45am
Radical Nephroureterectomy with Robotic Assistance: Should it be Standard Care?
Ashok Hemal, MD, MCh, FACS, FRCS7:45-7:55am
Optimal Management of Bladder Cuff
Mihir Desai, MD7:55-8:10am
Firefly and Upper Tract Reconstruction
Daniel Eun, MD8:10-8:15am
Q&A/Audience Response Question with App
SESSION II: KIDNEY I – PARTIAL NEPHRECTOMY
8:15-8:30am
Optimizing Robotic Partial Nephrectomy Outcome:
Lessons Learned Over 1,000 Procedures
Ketan K. Badani, MD 8:30-8:45am
Is There a Role for Partial Nephrectomy in Benign Tumors?
Ithaar H. Derweesh, MD8:45-8:55am
Robotic Partial Nephrectomy: The Italian Experience
Umberto Capitanio, MD8:55-9:05am
Robotic Partial Nephrectomy: The Asia/Japan Experience
Ryoichi Shiroki, MD, PhD9:05-9:15am
Optimizing the Retroperitoneal Approach
James Porter, MD9:15-9:30am
Lessons on Medical Leadership
Ralph V. Clayman, MD, MBA9:30-9:40am
Robotic Surgery in Kidney Transplant World
Michael A. Palese, MD9:40-9:45am
Q&A
9:45-10:00am
BREAK / VISIT EXHIBITS
10:00-11:15am
3D Live Surgery: Robot-Assisted Partial Nephrectomy
Surgeon:
11:15-11:50am
DEBATE: Single Port Surgery for Kidney
Chairs:
CON:
Judge:
11:50-12:00pm
3-D Imaging Applications for Robotic Surgery: Evaluation of Surgeons’ Perceptions
Prof. Francesco Porpiglia, MD12:00-1:00pm
LUNCH
SESSION III: KIDNEY CANCER II
1:00-1:10pm
SURS President Welcome Address
Jihad Kaouk, MD1:10-1:20pm
Establishing Office-Based Renal Mass Biopsy: An Update on Outcome
Jaime Landman, MD1:20-1:35pm
Robotic Partial Nephrectomy for T1b/T2a Renal Masses: Are We Overdoing It?
Brian Shuch, MD1:35-1:45pm
Renal Function After Partial Nephrectomy –
Is Renal Ischemia, Volume Preservation, or Both Equally Important?
Dipen Parekh, MD 1:45-1:55pm
Selective Clamping: Update on Outcomes and Data
Michael Stifelman, MD1:55-2:10pm
The Role of Robotic Radical Nephrectomy
Ketan K. Badani, MD2:10-2:25pm
DEBATE: Is There Still a Role for Cytoreductive Surgery in Advanced Renal Cell
Carcinoma?
PRO:
CON:
2:25-2:30pm
Audience Response Question with App / BREAK
SESSION IV: BLADDER CANCER
2:30-4:55pm
3D Live Surgery: Robot-Assisted Radical Cystectomy
Surgeon:
2:30-4:55pm
CONCURRENT 10 MINUTE LECTURES
New Clinical Trial Designs in Urothelial Carcinoma
Bishoy Morris Faltas, MDZero Narcotic Protocol for Robotic Cystectomy: Surgical and Anesthesia Considerations
John Sfakianos, MD Alan Sim, MDStandardizing Training with a “Top Down Approach”: Conclusions from a
Train the Trainer Delphi Process
Justin Collins, MBChB, MD, FRCS Intracorporeal Urinary Diversion for Robotic Radical Cystectomy
Alvin Goh, MDDo All Patients with Muscle Invasive Bladder Cancer Require Neoadjuvant Chemotherapy? A Review of Evidence
Hugh Lavery, MD4:55-5:00pm
End of Symposium Conclusion
Ash Tewari, MBBS, MCh
To obtain additional details on Exhibiting at the symposium,
please contact Jennifer Berens, Gaffney Events
425.442.1314 | jennifer@gaffneyevents.com
Presented by Mount Sinai Department of Urology in collaboration with Society of Urologic Robotic Surgeons and Endourological Society
